Article Details

Novartis trial shows no benefits from Pear's schizophrenia app as CEO cites trial irregularities

Retrieved on: 2021-01-13 20:57:47

Tags for this article:

Click the tags to see associated articles and topics

Novartis trial shows no benefits from Pear's schizophrenia app as CEO cites trial irregularities. View article details on hiswai:

Excerpt

Digital therapeutics are still in early days and to some extent are still proving themselves to the larger biopharma and health tech communities.

Article found on: www.mobihealthnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo